Total Payments
$4,156
2024 Payments
$1,555
Companies
28
Transactions
172
Medicare Patients
3,713
Medicare Billing
$399,797
Payment Breakdown by Category
Food & Beverage$3,606 (86.8%)
Travel$460.60 (11.1%)
Education$89.25 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,606 | 169 | 86.8% |
| Travel and Lodging | $460.60 | 1 | 11.1% |
| Education | $89.25 | 2 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,249 | 64 | $0 (2024) |
| Boston Scientific Corporation | $1,002 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $261.64 | 12 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $241.82 | 15 | $0 (2024) |
| Olympus America Inc. | $154.08 | 3 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $139.86 | 8 | $0 (2024) |
| GENZYME CORPORATION | $136.72 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $119.48 | 6 | $0 (2024) |
| Celgene Corporation | $116.40 | 6 | $0 (2024) |
| Ardelyx, Inc. | $101.41 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,555 | 72 | ABBVIE INC. ($692.02) |
| 2023 | $1,049 | 55 | ABBVIE INC. ($365.45) |
| 2022 | $273.31 | 17 | ABBVIE INC. ($135.35) |
| 2021 | $387.80 | 10 | BOSTON SCIENTIFIC CORPORATION ($131.20) |
| 2020 | $33.27 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($17.96) |
| 2019 | $765.19 | 10 | Boston Scientific Corporation ($750.75) |
| 2018 | $49.58 | 3 | Synergy Pharmaceuticals Inc ($19.26) |
| 2017 | $43.46 | 3 | BOSTON SCIENTIFIC CORPORATION ($18.77) |
All Payment Transactions
172 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: VIROLOGY | ||||||
| 12/05/2024 | Enterra Medical, Inc. | — | Food and Beverage | In-kind items and services | $30.65 | General |
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $31.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.87 | General |
| 11/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/08/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Immunology | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/01/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: VIROLOGY | ||||||
| 09/05/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: GI | ||||||
| 08/29/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 850 | 990 | $887,986 | $91,668 |
| 2022 | 16 | 897 | 1,080 | $718,324 | $100,064 |
| 2021 | 16 | 846 | 1,033 | $350,232 | $87,765 |
| 2020 | 20 | 1,120 | 1,529 | $494,946 | $120,300 |
Total Patients
3,713
Total Services
4,632
Medicare Billing
$399,797
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 102 | 103 | $218,360 | $19,333 | 8.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 124 | 183 | $38,430 | $12,289 | 32.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 55 | 59 | $16,874 | $7,661 | 45.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 79 | 79 | $138,250 | $7,468 | 5.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 142 | 145 | $210,250 | $7,186 | 3.4% |
| 46221 | Removal of external hemorrhoids by rubber banding | Facility | 2023 | 16 | 41 | $16,795 | $5,769 | 34.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 46 | 46 | $36,800 | $4,093 | 11.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 72 | 90 | $17,730 | $4,082 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 52 | 52 | $15,808 | $4,047 | 25.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 41 | $6,535 | $3,695 | 56.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 22 | 22 | $20,460 | $3,417 | 16.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 23 | 25 | $40,000 | $3,208 | 8.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $15,062 | $2,815 | 18.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 29 | $31,900 | $2,284 | 7.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 28 | 38 | $4,332 | $2,275 | 52.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 14 | 20 | $60,400 | $2,048 | 3.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 83 | 86 | $141,000 | $16,171 | 11.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 120 | 175 | $36,750 | $12,318 | 33.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 57 | 60 | $17,160 | $8,965 | 52.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 99 | 99 | $30,096 | $8,263 | 27.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 79 | 79 | $125,340 | $8,075 | 6.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 139 | 141 | $170,123 | $7,788 | 4.6% |
| 46221 | Removal of external hemorrhoids by rubber banding | Facility | 2022 | 18 | 47 | $15,510 | $6,736 | 43.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 47 | 84 | $13,020 | $6,420 | 49.3% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 30 | 30 | $27,900 | $5,244 | 18.8% |
About Dr. Eric Plott, MD
Dr. Eric Plott, MD is a Gastroenterology healthcare provider based in Gulfport, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346466596.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Plott, MD has received a total of $4,156 in payments from pharmaceutical and medical device companies, with $1,555 received in 2024. These payments were reported across 172 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,606).
As a Medicare-enrolled provider, Plott has provided services to 3,713 Medicare beneficiaries, totaling 4,632 services with total Medicare billing of $399,797. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Gulfport, MS
- Active Since 04/17/2007
- Last Updated 02/08/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346466596
Products in Payments
- SPYGLASS (Device) $750.75
- RINVOQ (Biological) $510.09
- SKYRIZI (Biological) $272.04
- XIFAXAN (Drug) $199.91
- STELARA (Biological) $143.13
- LINZESS (Drug) $142.81
- Linzess (Drug) $139.86
- DUPIXENT (Biological) $136.72
- EXALT (Device) $131.20
- VISIGLIDE (Device) $127.52
- REMICADE (Biological) $118.51
- VIBERZI (Drug) $117.96
- ZEPOSIA (Drug) $116.40
- IBSRELA (Drug) $101.41
- OMVOH (Drug) $96.45
- Axios (Device) $87.82
- ENTYVIO (Biological) $83.66
- CREON (Drug) $82.54
- VEGZELMA (Biological) $78.70
- ZENPEP (Drug) $70.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.